Metabolon develops analytical methods and software for biomarker discovery by using metabolomics.
Metabolon is a technology company, develops analytical methods and software for biomarker discovery using metabolomics. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. Metabolon provides a unique, real-time fingerprint of biological system to reveal novel discoveries and realize the promise of precision medicine.The company can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of the disease, medical intervention, diet, or the environment. This deep and comprehensive view of the metabolome provides biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers to some of biology’s most difficult questions.Metabolon was founded in 2000 and headquartered in Durham, North Carolina.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 27, 2009 | Series C | $6.20M | 1 | — | — | Detail |
Mar 27, 2008 | Series C | $3.05M | 1 | — | — | Detail |
Jan 18, 2006 | Series B | $8M | 1 | — | — | Detail |
Oct 13, 2004 | Series A | $5M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
The Trelys Funds | — | Series C |